This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...